IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,288,250 | +1.8% | 425,000 | 0.0% | 0.08% | +44.2% |
| Q3 2022 | $4,212,000 | +1.0% | 425,000 | 0.0% | 0.05% | +18.2% |
| Q2 2022 | $4,169,000 | 0.0% | 425,000 | 0.0% | 0.04% | +37.5% |
| Q1 2022 | $4,169,000 | +0.9% | 425,000 | 0.0% | 0.03% | -8.6% |
| Q4 2021 | $4,131,000 | +0.3% | 425,000 | 0.0% | 0.04% | +2.9% |
| Q3 2021 | $4,118,000 | +0.2% | 425,000 | 0.0% | 0.03% | +13.3% |
| Q2 2021 | $4,110,000 | – | 425,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |